• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[术后感染性疝的外科治疗]

[Surgical treatment of postoperative infected hernias].

作者信息

Andreev S D, Adamian A A, Usenov D A

出版信息

Khirurgiia (Mosk). 1991 May(5):82-6.

PMID:2072654
Abstract

The article deals with the results of examination and treatment of 153 patients with postoperative ventral hernias. In 109 (71.3%) of these patients the hernia formed due to suppuration of the wound after the first operation; 48 (31.4%) hab on admission a source of purulent surgical infection in the zone of the future operative intervention. According to the findings of microbiological examination of intraoperative biopsies and smears taken from wounds and fistulas, the patients were divided into three groups (group 1, 10(1) microbial bodies per kg tissue; group 2, 10(2); group 3, 10(5)). Pharmacological studies showed that the necessary concentration of broad-spectrum antibiotics is produced only when they are injected by the infiltrative method. On basis of this, the authors developed a scheme for the prevention of purulent complications in herniotomy with the use of biological and synthetic prostheses for each group of patients. The method produced good results in the majority of patients with minimal suppurations (3.9%) and recurrent hernias (0.65%).

摘要

本文探讨了153例术后腹疝患者的检查和治疗结果。其中109例(71.3%)患者的疝是由于首次手术后伤口化脓形成的;48例(31.4%)患者在入院时,未来手术干预区域存在化脓性手术感染源。根据术中活检以及取自伤口和瘘管的涂片的微生物学检查结果,将患者分为三组(第1组,每千克组织中有10¹个微生物体;第2组,10²个;第3组,10⁵个)。药理学研究表明,只有通过浸润法注射广谱抗生素时,才能产生必要的浓度。基于此,作者为每组患者制定了一种使用生物和合成假体预防疝修补术中化脓性并发症的方案。该方法在大多数患者中取得了良好效果,化脓最少(3.9%),复发疝(0.65%)。

相似文献

1
[Surgical treatment of postoperative infected hernias].[术后感染性疝的外科治疗]
Khirurgiia (Mosk). 1991 May(5):82-6.
2
[Management of large abdominal wall hernias with foreign implant materials (Gore-Tex patch)].使用异体植入材料(戈尔泰克斯补片)治疗巨大腹壁疝
Zentralbl Chir. 1997;122(10):879-84.
3
[Possibilities of prognostication of suppurative-inflammatory complications of surgical treatment of patients with nonrecurrent postoperative ventral hernia].[非复发性术后腹疝患者手术治疗化脓性炎症并发症的预后评估可能性]
Vestn Khir Im I I Grek. 2000;159(1):68-72.
4
Factors affecting wound complications in repair of ventral hernias.影响腹疝修补术中伤口并发症的因素。
Am Surg. 1998 Mar;64(3):276-80.
5
[Hernioplasty with a dermal autograft in recurrent and postoperative hernias].复发性疝和术后疝的自体真皮移植疝修补术
Khirurgiia (Mosk). 2001(8):37-40.
6
[Some aspects of surgical treatment of postoperative ventral hernia].[术后腹疝的外科治疗的某些方面]
Khirurgiia (Mosk). 1995 Jan(1):51-3.
7
[Surgical treatment without recurrences ventral hernias as a social problem].[将腹疝手术治疗且无复发作为一个社会问题]
Vestn Khir Im I I Grek. 2006;165(1):15-7.
8
[Abdominal cicatricial hernia--results of various surgical techniques].
Swiss Surg. 1995(6):274-8.
9
Use of human acellular dermal matrix for hernia repair: friend or foe?人脱细胞真皮基质在疝修补术中的应用:是福是祸?
Surgery. 2008 Oct;144(4):703-9; discussion 709-11. doi: 10.1016/j.surg.2008.06.018. Epub 2008 Aug 29.
10
[Surgical treatment of large and giant postoperative ventral hernias].
Vestn Khir Im I I Grek. 1985 Feb;134(2):116-20.